Astrocyte immune responses in epilepsy
Open Access
- 31 July 2012
- Vol. 60 (8), 1258-1268
- https://doi.org/10.1002/glia.22312
Abstract
Astrocytes, the major glial cell type of the central nervous system (CNS), are known to play a major role in the regulation of the immune/inflammatory response in several human CNS diseases. In epilepsy-associated pathologies, the presence of astrogliosis has stimulated extensive research focused on the role of reactive astrocytes in the pathophysiological processes that underlie the development of epilepsy. In brain tissue from patients with epilepsy, astrocytes undergo significant changes in their physiological properties, including the activation of inflammatory pathways. Accumulating experimental evidence suggests that proinflammatory molecules can alter glio-neuronal communications contributing to the generation of seizures and seizure-related neuronal damage. In particular, both in vitro and in vivo data point to the role of astrocytes as both major source and target of epileptogenic inflammatory signaling. In this context, understanding the astroglial inflammatory response occurring in epileptic brain tissue may provide new strategies for targeting astrocyte-mediated epileptogenesis. This article reviews current evidence regarding the role of astrocytes in the regulation of the innate immune responses in epilepsy. Both clinical observations in drug-resistant human epilepsies and experimental findings in clinically relevant models will be discussed and elaborated, highlighting specific inflammatory pathways (such as interleukin-1 beta/toll-like receptor 4) that could be potential targets for antiepileptic, disease-modifying therapeutic strategies. (c) 2012 Wiley Periodicals, Inc.This publication has 150 references indexed in Scilit:
- A conceptual revolution in the relationships between the brain and immunityBrain, Behavior, and Immunity, 2011
- MHCI negatively regulates synapse density during the establishment of cortical connectionsNature Neuroscience, 2011
- Enhanced Epidermal Growth Factor, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor Expression in Tuberous Sclerosis ComplexThe American Journal of Pathology, 2011
- Crosstalk pathways between Toll-like receptors and the complement systemTrends in Immunology, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Viral-like brain inflammation during development causes increased seizure susceptibility in adult ratsNeurobiology of Disease, 2009
- Blood–brain barrier breakdown-inducing astrocytic transformation: Novel targets for the prevention of epilepsyEpilepsy Research, 2009
- Metabotropic Glutamate Receptors as Targets for Multipotential Treatment of Neurological DisordersNeurotherapeutics, 2009
- Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIBActa Neuropathologica, 2008
- P1 receptors and cytokine secretionPurinergic Signalling, 2007